(+)-schisandrin B multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CBR1 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO Cbr1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CBR1 mRNA CTD PMID:36331819 1,2-naphthoquinone multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of 1 and 2-naphthoquinone] CTD PMID:23295225 1,4-dithiothreitol multiple interactions EXP 6480464 Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] CTD PMID:21256830 1,4-naphthoquinone multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1 and 4-naphthoquinone] CTD PMID:23295225 13-dihydrodaunorubicin multiple interactions EXP 6480464 [[Curcumin binds to and results in decreased activity of CBR1 protein] which results in decreased reduction of Daunorubicin] which results in decreased chemical synthesis of daunorubicinol more ... CTD PMID:20670211 and PMID:25541467 17alpha-ethynylestradiol affects expression ISO Cbr1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of CBR1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO Cbr1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBR1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO Cbr1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CBR1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CBR1 mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cbr1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CBR1 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBR1 mRNA CTD PMID:16214954 and PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CBR1 protein CTD PMID:19492234 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CBR1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of CBR1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cbr1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CBR1 mRNA CTD PMID:20702594 and PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cbr1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CBR1 mRNA CTD PMID:18796159 and PMID:19933214 2,4-dinitrotoluene affects expression ISO Cbr1 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO Cbr1 (Rattus norvegicus) 6480464 2 and 6-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 2-acetamidofluorene increases expression ISO Cbr1 (Mus musculus) 6480464 2-Acetylaminofluorene results in increased expression of CBR1 mRNA CTD PMID:21607683 2-amino-14,16-dimethyloctadecan-3-ol decreases expression EXP 6480464 2-amino-14 and 16-dimethyloctadecan-3-ol results in decreased expression of CBR1 protein CTD PMID:32044396 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of CBR1 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl affects expression ISO Cbr1 (Mus musculus) 6480464 3 more ... CTD PMID:20702594 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions EXP 6480464 Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] more ... CTD PMID:11306090 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases metabolic processing EXP 6480464 CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11306090 4-amino-2,6-dinitrotoluene affects expression ISO Cbr1 (Rattus norvegicus) 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 4-Benzoylpyridine multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 4-benzoylpyridine] CTD PMID:23295225 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Omeprazole affects the expression of CBR1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Propylthiouracil affects the expression of CBR1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of CBR1 mRNA CTD PMID:24780913 and PMID:30047161 9,10-phenanthroquinone multiple interactions EXP 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 and PMID:23295225 9,10-phenanthroquinone increases metabolic processing EXP 6480464 CBR1 protein results in increased metabolism of 9 and 10-phenanthrenequinone CTD PMID:29108775 Aloe emodin decreases activity EXP 6480464 aloe emodin results in decreased activity of CBR1 protein CTD PMID:35065925 amiodarone affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Amiodarone affects the expression of CBR1 mRNA CTD PMID:19483382 amitrole increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Amitrole results in increased expression of CBR1 mRNA CTD PMID:30047161 ammonium chloride affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CBR1 mRNA CTD PMID:16483693 andrographolide multiple interactions ISO Cbr1 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA CTD PMID:19737545 antimonite multiple interactions EXP 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 antimycin A decreases expression EXP 6480464 Antimycin A results in decreased expression of CBR1 mRNA CTD PMID:33512557 aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of CBR1 protein CTD PMID:33212167 arsenite(3-) multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of CBR1 mRNA more ... CTD PMID:32076005 and PMID:32406909 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CBR1 mRNA CTD PMID:22719067 arsenous acid decreases response to substance EXP 6480464 CBR1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22719067 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of CBR1 mRNA CTD PMID:22378314 benzbromarone affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Benzbromarone affects the expression of CBR1 mRNA CTD PMID:19483382 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CBR1 mRNA and Benzo(a)pyrene results in increased expression of CBR1 protein CTD PMID:22531821 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of CBR1 exon CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO Cbr1 (Mus musculus) 6480464 [lipopolysaccharide and E coli O55-B5 co-treated with Benzo(a)pyrene] affects the expression of CBR1 mRNA CTD PMID:28987381 benzo[a]pyrene increases expression ISO Cbr1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CBR1 mRNA CTD PMID:19770486 more ... beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CBR1 mRNA CTD PMID:17569794 and PMID:19737606 beta-naphthoflavone multiple interactions ISO Cbr1 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA CTD PMID:19737545 bexarotene increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Bexarotene results in increased expression of CBR1 mRNA CTD PMID:16648578 bisphenol A multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CBR1 mRNA and [bisphenol A co-treated with Testosterone] results in increased expression of CBR1 mRNA CTD PMID:26496021 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CBR1 protein CTD PMID:37567409 bisphenol A increases expression ISO Cbr1 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CBR1 mRNA CTD PMID:25181051 Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of CBR1 protein CTD PMID:34186270 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of CBR1 protein CTD PMID:34186270 butylated hydroxyanisole increases expression EXP 6480464 Butylated Hydroxyanisole results in increased expression of CBR1 mRNA and Butylated Hydroxyanisole results in increased expression of CBR1 protein CTD PMID:23247010 captan increases expression ISO Cbr1 (Mus musculus) 6480464 Captan results in increased expression of CBR1 mRNA CTD PMID:31558096 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of CBR1 mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO Cbr1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to CBR1 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 chloroprene increases expression ISO Cbr1 (Mus musculus) 6480464 Chloroprene results in increased expression of CBR1 mRNA CTD PMID:23125180 ciprofibrate increases expression ISO Cbr1 (Mus musculus) 6480464 ciprofibrate results in increased expression of CBR1 mRNA CTD PMID:12771043 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CBR1 mRNA CTD PMID:27392435 clofibrate affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Clofibrate affects the expression of CBR1 mRNA CTD PMID:19483382 Clofop increases reduction EXP 6480464 CBR1 protein results in increased reduction of fenofibric acid CTD PMID:27599626 coumarin increases expression ISO Cbr1 (Rattus norvegicus) 6480464 coumarin results in increased expression of CBR1 mRNA CTD PMID:18480146 coumestrol increases expression EXP 6480464 Coumestrol results in increased expression of CBR1 mRNA CTD PMID:19167446 Cuprizon increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of CBR1 mRNA CTD PMID:26577399 curcumin multiple interactions EXP 6480464 [[Curcumin binds to and results in decreased activity of CBR1 protein] which results in decreased reduction of Daunorubicin] which results in decreased chemical synthesis of daunorubicinol more ... CTD PMID:25541467 cyclosporin A decreases expression ISO Cbr1 (Mus musculus) 6480464 Cyclosporine results in decreased expression of CBR1 mRNA CTD PMID:19770486 cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CBR1 mRNA CTD PMID:20106945 and PMID:25562108 daunorubicin increases metabolic processing EXP 6480464 CBR1 protein results in increased metabolism of Daunorubicin and CBR1 results in increased metabolism of Daunorubicin CTD PMID:20670211 and PMID:30849340 daunorubicin increases reduction EXP 6480464 CBR1 protein results in increased reduction of Daunorubicin CTD PMID:18579125 and PMID:25541467 daunorubicin decreases metabolic processing EXP 6480464 CBR1 gene SNP results in decreased metabolism of Daunorubicin CTD PMID:19204081 daunorubicin multiple interactions EXP 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:20670211 more ... deguelin decreases expression EXP 6480464 deguelin results in decreased expression of CBR1 mRNA CTD PMID:33512557 deoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 dexamethasone decreases expression ISO Cbr1 (Mus musculus) 6480464 Dexamethasone results in decreased expression of CBR1 mRNA CTD PMID:22733784 dextran sulfate decreases expression ISO Cbr1 (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of CBR1 protein CTD PMID:35999755 diarsenic trioxide decreases response to substance EXP 6480464 CBR1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22719067 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CBR1 mRNA CTD PMID:22719067 dibenzofurans increases expression ISO Cbr1 (Mus musculus) 6480464 Dibenzofurans results in increased expression of CBR1 mRNA CTD PMID:34254344 dibutyl phthalate decreases expression ISO Cbr1 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of CBR1 mRNA CTD PMID:17361019 and PMID:21266533 dibutyl phthalate decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of CBR1 mRNA CTD PMID:21266533 diclofenac affects expression EXP 6480464 Diclofenac affects the expression of CBR1 mRNA CTD PMID:24752500 diethyl maleate increases expression ISO Cbr1 (Mus musculus) 6480464 diethyl maleate results in increased expression of CBR1 mRNA CTD PMID:25270620 dioxygen multiple interactions EXP 6480464 3 more ... CTD PMID:24975222 dioxygen multiple interactions ISO Cbr1 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBR1 mRNA CTD PMID:30529165 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of CBR1 mRNA and Oxygen deficiency results in increased expression of CBR1 protein CTD PMID:24975222 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions EXP 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 diquat increases expression ISO Cbr1 (Mus musculus) 6480464 Diquat results in increased expression of CBR1 mRNA CTD PMID:36851058 diuron decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Diuron results in decreased expression of CBR1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA CTD PMID:27188386 doxorubicin affects reduction EXP 6480464 CBR1 protein affects the reduction of Doxorubicin CTD PMID:18635746 doxorubicin multiple interactions EXP 6480464 [resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin CTD PMID:24064738 doxorubicin increases response to substance ISO Cbr1 (Mus musculus) 6480464 CBR1 protein results in increased susceptibility to Doxorubicin CTD PMID:11016643 and PMID:14583452 doxorubicin increases reduction EXP 6480464 CBR1 protein results in increased reduction of Doxorubicin CTD PMID:18755171 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CBR1 protein CTD PMID:18755171 doxorubicin decreases metabolic processing EXP 6480464 CBR1 gene SNP results in decreased metabolism of Doxorubicin CTD PMID:19204081 emodin decreases activity EXP 6480464 Emodin results in decreased activity of CBR1 protein CTD PMID:35065925 endosulfan increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of CBR1 mRNA CTD PMID:29391264 etacrynic acid multiple interactions EXP 6480464 Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 ethanol affects expression ISO Cbr1 (Mus musculus) 6480464 Ethanol affects the expression of CBR1 mRNA CTD PMID:30319688 ethanol increases expression ISO Cbr1 (Mus musculus) 6480464 Ethanol results in increased expression of CBR1 mRNA CTD PMID:30319688 fenpyroximate decreases expression EXP 6480464 fenpyroximate results in decreased expression of CBR1 mRNA CTD PMID:33512557 fenthion increases expression ISO Cbr1 (Mus musculus) 6480464 Fenthion results in increased expression of CBR1 mRNA CTD PMID:34813904 flutamide increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Flutamide results in increased expression of CBR1 mRNA CTD PMID:24136188 folpet increases expression ISO Cbr1 (Mus musculus) 6480464 folpet results in increased expression of CBR1 mRNA CTD PMID:31558096 FR900359 increases phosphorylation EXP 6480464 FR900359 results in increased phosphorylation of CBR1 protein CTD PMID:37730182 Frangulin A decreases activity EXP 6480464 frangulin A results in decreased activity of CBR1 protein CTD PMID:35065925 Frangulin B decreases activity EXP 6480464 frangulin B results in decreased activity of CBR1 protein CTD PMID:35065925 furan increases expression ISO Cbr1 (Mus musculus) 6480464 furan results in increased expression of CBR1 mRNA CTD PMID:24183702 furan increases expression ISO Cbr1 (Rattus norvegicus) 6480464 furan results in increased expression of CBR1 mRNA CTD PMID:25539665 genistein increases expression EXP 6480464 Genistein results in increased expression of CBR1 mRNA CTD PMID:16705744 genistein increases expression ISO Cbr1 (Mus musculus) 6480464 Genistein results in increased expression of CBR1 mRNA CTD PMID:34942354 genistein multiple interactions ISO Cbr1 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of CBR1 mRNA CTD PMID:34942354 genistein multiple interactions EXP 6480464 [Genistein co-treated with NADP] binds to CBR1 protein CTD PMID:25526675 glycochenodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 glycocholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 glycodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 griseofulvin affects expression ISO Cbr1 (Mus musculus) 6480464 Griseofulvin affects the expression of CBR1 mRNA CTD PMID:12735108 hexane-2,3-dione increases reduction EXP 6480464 CBR1 protein results in increased reduction of 2 and 3-hexanedione CTD PMID:25541467 and PMID:30849340 hexane-2,3-dione multiple interactions EXP 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased reduction of 2 more ... CTD PMID:23295225 more ... hydrazine increases expression ISO Cbr1 (Mus musculus) 6480464 hydrazine results in increased expression of CBR1 mRNA CTD PMID:15282401 indometacin increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Indomethacin results in increased expression of CBR1 mRNA CTD PMID:18299717 inulin multiple interactions ISO Cbr1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CBR1 mRNA CTD PMID:36331819 isatin multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of Isatin] CTD PMID:23295225 Isoxanthohumol multiple interactions EXP 6480464 isoxanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 Isoxanthohumol decreases activity EXP 6480464 isoxanthohumol results in decreased activity of CBR1 protein CTD PMID:35065925 ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of CBR1 protein CTD PMID:32959892 L-1,4-dithiothreitol multiple interactions EXP 6480464 Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] CTD PMID:21256830 L-ethionine affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Ethionine affects the expression of CBR1 mRNA CTD PMID:19483382 leflunomide increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Leflunomide results in increased expression of CBR1 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions EXP 6480464 CBR1 protein modified form inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] more ... CTD PMID:25818598 m-xylene increases expression ISO Cbr1 (Rattus norvegicus) 6480464 3-xylene results in increased expression of CBR1 mRNA CTD PMID:12815608 menadione increases metabolic processing EXP 6480464 CBR1 protein results in increased metabolism of Vitamin K 3 CTD PMID:19061875 menadione multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of Vitamin K 3] and Vitamin K 3 inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 and PMID:23295225 methamphetamine decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Methamphetamine results in decreased expression of CBR1 mRNA CTD PMID:15644446 methimazole increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Methimazole results in increased expression of CBR1 mRNA CTD PMID:30047161 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of CBR1 mRNA CTD PMID:27188386 microcystin-LR increases expression ISO Cbr1 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of CBR1 mRNA CTD PMID:17654400 mono(2-ethylhexyl) phthalate multiple interactions ISO Cbr1 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of CBR1 mRNA CTD PMID:34942354 monosodium L-glutamate increases activity ISO Cbr1 (Mus musculus) 6480464 Sodium Glutamate results in increased activity of CBR1 protein CTD PMID:25473020 N-methyl-N-nitrosourea increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Methylnitrosourea results in increased expression of CBR1 mRNA CTD PMID:16525678 N-nitrosodiethylamine increases expression ISO Cbr1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CBR1 mRNA CTD PMID:12771043 and PMID:21607683 N-nitrosodiethylamine increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Diethylnitrosamine results in increased expression of CBR1 mRNA CTD PMID:19638242 N-nitrosomorpholine increases expression ISO Cbr1 (Rattus norvegicus) 6480464 N-nitrosomorpholine results in increased expression of CBR1 mRNA CTD PMID:19716841 NADP zwitterion multiple interactions EXP 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 more ... NADP(+) multiple interactions EXP 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 more ... naphthalenes multiple interactions EXP 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of Naphthalenes CTD PMID:21910479 naphthalenes increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Naphthalenes results in increased expression of CBR1 protein CTD PMID:17337753 nefazodone multiple interactions EXP 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 nefazodone increases expression ISO Cbr1 (Rattus norvegicus) 6480464 nefazodone results in increased expression of CBR1 mRNA CTD PMID:24136188 nimesulide increases expression ISO Cbr1 (Rattus norvegicus) 6480464 nimesulide results in increased expression of CBR1 mRNA CTD PMID:24136188 omeprazole affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Omeprazole affects the expression of CBR1 mRNA CTD PMID:19483382 oxcarbazepine increases reduction EXP 6480464 CBR1 protein results in increased reduction of oxcarbazepine CTD PMID:25063510 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CBR1 mRNA CTD PMID:22230336 and PMID:29067470 paracetamol affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Acetaminophen affects the expression of CBR1 mRNA CTD PMID:18246545 paracetamol decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of CBR1 mRNA CTD PMID:18246545 parathion increases expression ISO Cbr1 (Mus musculus) 6480464 Parathion results in increased expression of CBR1 mRNA CTD PMID:34813904 pentachlorophenol increases expression ISO Cbr1 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of CBR1 mRNA CTD PMID:23892564 perfluorohexanesulfonic acid increases expression ISO Cbr1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of CBR1 mRNA CTD PMID:37995155 perfluorooctane-1-sulfonic acid multiple interactions ISO Cbr1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CBR1 mRNA more ... CTD PMID:36331819 perfluorooctanoic acid increases expression ISO Cbr1 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of CBR1 mRNA CTD PMID:19162173 phenobarbital multiple interactions ISO Cbr1 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CBR1 mRNA] CTD PMID:19482888 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CBR1 protein CTD PMID:35881160 phenobarbital increases expression ISO Cbr1 (Mus musculus) 6480464 Phenobarbital results in increased expression of CBR1 mRNA and Phenobarbital results in increased expression of CBR1 protein CTD PMID:19482888 more ... phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 CBR1 protein modified form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1B mRNA] more ... CTD PMID:25818598 phorone affects expression ISO Cbr1 (Rattus norvegicus) 6480464 phorone affects the expression of CBR1 mRNA CTD PMID:18198479 pirinixic acid multiple interactions ISO Cbr1 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CBR1 mRNA and PPARA protein promotes the reaction [pirinixic acid results in increased expression of CBR1 mRNA] CTD PMID:19710929 and PMID:20059764 pirinixic acid affects expression ISO Cbr1 (Rattus norvegicus) 6480464 pirinixic acid affects the expression of CBR1 mRNA CTD PMID:19483382 pirinixic acid increases expression ISO Cbr1 (Rattus norvegicus) 6480464 pirinixic acid results in increased expression of CBR1 mRNA CTD PMID:19162173 and PMID:22484513 pirinixic acid increases expression ISO Cbr1 (Mus musculus) 6480464 pirinixic acid results in increased expression of CBR1 mRNA CTD PMID:18301758 more ... potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of CBR1 mRNA CTD PMID:22714537 propiconazole increases expression ISO Cbr1 (Mus musculus) 6480464 propiconazole results in increased expression of CBR1 mRNA CTD PMID:21278054 quercetin multiple interactions EXP 6480464 [Quercetin co-treated with NADP] binds to CBR1 protein more ... CTD PMID:11306090 more ... rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of CBR1 mRNA CTD PMID:30851411 Rebamipide increases expression ISO Cbr1 (Rattus norvegicus) 6480464 rebamipide results in increased expression of CBR1 mRNA CTD PMID:18299717 resveratrol multiple interactions ISO Cbr1 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CBR1 mRNA] CTD PMID:31298478 resveratrol affects binding EXP 6480464 CBR1 protein binds to resveratrol CTD PMID:24064738 resveratrol multiple interactions EXP 6480464 [resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin more ... CTD PMID:24064738 and PMID:24975222 rotenone increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Rotenone results in increased expression of CBR1 mRNA CTD PMID:28374803 rutin multiple interactions EXP 6480464 Rutin binds to and results in decreased activity of CBR1 protein and Rutin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 and PMID:18579125 S-nitrosoglutathione multiple interactions EXP 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1 more ... CTD PMID:21256830 and PMID:23295225 S-nitrosoglutathione increases reduction EXP 6480464 CBR1 protein results in increased reduction of S-Nitrosoglutathione CTD PMID:21256830 SB 431542 multiple interactions EXP 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CBR1 mRNA CTD PMID:28595984 and PMID:34032870 sodium arsenite decreases expression ISO Cbr1 (Rattus norvegicus) 6480464 sodium arsenite results in decreased expression of CBR1 protein CTD PMID:29459688 sodium arsenite multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 sodium dichromate decreases expression ISO Cbr1 (Mus musculus) 6480464 sodium bichromate results in decreased expression of CBR1 mRNA CTD PMID:22155349 sophoraflavanone B multiple interactions EXP 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 streptozocin decreases activity ISO Cbr1 (Rattus norvegicus) 6480464 Streptozocin results in decreased activity of CBR1 protein CTD PMID:11057757 T-2 toxin affects expression ISO Cbr1 (Rattus norvegicus) 6480464 T-2 Toxin affects the expression of CBR1 protein CTD PMID:26141394 tebufenpyrad decreases expression EXP 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of CBR1 mRNA CTD PMID:33512557 testosterone multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of CBR1 mRNA CTD PMID:26496021 testosterone enanthate affects expression EXP 6480464 testosterone enanthate affects the expression of CBR1 mRNA CTD PMID:17440010 tetrachloroethene increases expression ISO Cbr1 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of CBR1 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO Cbr1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CBR1 mRNA CTD PMID:27339419 tetrachloromethane increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of CBR1 mRNA CTD PMID:30723492 and PMID:31150632 tetrachloromethane multiple interactions ISO Cbr1 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CBR1 mRNA] CTD PMID:31150632 tetrachloromethane affects expression ISO Cbr1 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of CBR1 mRNA CTD PMID:31919559 thalidomide decreases expression ISO Cbr1 (Mus musculus) 6480464 Thalidomide results in decreased expression of CBR1 mRNA CTD PMID:26217789 thapsigargin increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Thapsigargin results in increased expression of CBR1 protein CTD PMID:35544339 thioacetamide affects expression ISO Cbr1 (Rattus norvegicus) 6480464 Thioacetamide affects the expression of CBR1 mRNA CTD PMID:19483382 thioacetamide increases expression ISO Cbr1 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of CBR1 mRNA CTD PMID:23411599 and PMID:34492290 tiaprofenic acid increases reduction EXP 6480464 CBR1 protein results in increased reduction of tiaprofenic acid CTD PMID:28322780 titanium dioxide increases expression ISO Cbr1 (Mus musculus) 6480464 titanium dioxide results in increased expression of CBR1 mRNA CTD PMID:23131501 and PMID:31298478 titanium dioxide multiple interactions ISO Cbr1 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CBR1 mRNA] CTD PMID:31298478 triclosan multiple interactions EXP 6480464 [Triclosan co-treated with NADP] binds to CBR1 protein CTD PMID:25526675 undecane increases expression ISO Cbr1 (Rattus norvegicus) 6480464 undecane results in increased expression of CBR1 protein CTD PMID:17337753 valdecoxib increases expression ISO Cbr1 (Rattus norvegicus) 6480464 valdecoxib results in increased expression of CBR1 mRNA CTD PMID:24136188 valproic acid affects expression ISO Cbr1 (Mus musculus) 6480464 Valproic Acid affects the expression of CBR1 mRNA CTD PMID:17292431 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CBR1 mRNA CTD PMID:23179753 more ... valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CBR1 mRNA CTD PMID:25979313 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of CBR1 gene CTD PMID:29154799 vancomycin increases expression ISO Cbr1 (Mus musculus) 6480464 Vancomycin results in increased expression of CBR1 mRNA CTD PMID:18930951 xanthohumol multiple interactions EXP 6480464 xanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 zearalenone decreases expression ISO Cbr1 (Mus musculus) 6480464 Zearalenone results in decreased expression of CBR1 protein CTD PMID:36252740 zoledronic acid decreases expression EXP 6480464 zoledronic acid results in decreased expression of CBR1 mRNA CTD PMID:24714768
